On June 18-19, the MTN held a stakeholder consultation in Kampala, Uganda on two HIV prevention studies currently being planned – DELIVER (MTN-042), for pregnant women, and B-PROTECTED (MTN-043), for women who are breastfeeding. The meeting included 60 stakeholders who shared their thoughts about the studies before the anticipated start later this year/early 2020. The DELIVER and B-PROTECTED studies will evaluate the safety of two HIV prevention methods – the monthly dapivirine vaginal ring and daily use of Truvada as PrEP. Topics addressed during the meeting include regulatory plans, study implementation and ongoing community engagement. The meeting was co-hosted by AVAC, The White Ribbon Alliance Uganda, The International Community of Women Living with HIV Eastern Africa and the Makerere University-Johns Hopkins University (MUJHU) Research Collaboration.